Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Instil Bio, Inc. is a biopharmaceutical company focused on developing novel immunotherapies for cancer. Its pipeline includes bispecific antibodies targeting PD-L1 and VEGF, as well as other immune-modulating agents. The company collaborates globally, advancing clinical trials for solid tumor treatments, and aims to commercialize approved therapies. Its core strengths lie in innovative biologic platforms, strategic licensing, and a focus on unmet medical needs in oncology.
This description was generated via AI from an annual report. Updated about 1 year ago.